{"id":1922,"date":"2026-10-06T10:23:11","date_gmt":"2026-10-06T08:23:11","guid":{"rendered":"https:\/\/methysdx.com\/?p=1922"},"modified":"2026-10-06T10:23:11","modified_gmt":"2026-10-06T08:23:11","slug":"ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology","status":"publish","type":"post","link":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/","title":{"rendered":"FFCD and METHYS Dx: A Partnership Driving Innovation in Digestive Oncology"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-1920\" src=\"https:\/\/methysdx.com\/wp-content\/uploads\/2026\/10\/ffcd2-300x278.png\" alt=\"\" width=\"300\" height=\"278\" srcset=\"https:\/\/methysdx.com\/wp-content\/uploads\/2026\/10\/ffcd2-300x278.png 300w, https:\/\/methysdx.com\/wp-content\/uploads\/2026\/10\/ffcd2.png 678w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>The F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive (FFCD) and METHYS Dx have decided to combine their expertise to contribute to the development of new approaches aimed at improving the monitoring of patients with digestive cancers.<\/p>\n<p>This partnership reflects a shared ambition: to advance clinical research and foster the emergence of innovative tools to support increasingly personalized and effective patient care.<\/p>\n<p>Founded in 2021, METHYS Dx is a French DeepTech company specializing in the development of liquid biopsy solutions for the non-invasive follow-up of cancer patients. Through the analysis of circulating tumor DNA (ctDNA) and its proprietary methylation signatures, the company is developing highly sensitive tests designed to support clinicians in therapeutic decision-making and strengthen precision medicine approaches.<\/p>\n<p>For more than forty years, the FFCD has been a major player in clinical research in digestive oncology. Through the design and conduct of multicenter clinical trials, it actively contributes to advancing scientific knowledge and medical practice for the benefit of patients.<\/p>\n<p>At the heart of this collaboration is a shared conviction: clinical research is a key driver in bringing forward innovations that will transform the management of digestive cancers. By combining their respective expertise, the FFCD and METHYS Dx aim to develop projects that assess and demonstrate the potential of liquid biopsy technologies in patient monitoring.<\/p>\n<p>The solutions developed by METHYS Dx offer promising opportunities for more precise, less invasive monitoring that is better tailored to the individual needs of patients. By leveraging the FFCD\u2019s scientific and clinical expertise, this partnership aims to accelerate the generation of new knowledge and facilitate the translation of research advances into clinical practice.<\/p>\n<p>More than a collaboration, this partnership reflects a shared commitment to bringing academic research, clinical research, and technological innovation closer together in order to address the current and future challenges of digestive oncology.<\/p>\n<p>Together, the FFCD and METHYS Dx share the conviction that collaboration among stakeholders across the healthcare ecosystem is essential to developing practical solutions and achieving lasting improvements in the patient care pathway.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive (FFCD) and METHYS Dx have decided to combine their expertise to contribute to the development of new approaches aimed at improving the monitoring of patients with digestive cancers. This partnership reflects a shared ambition: to advance clinical research and foster the emergence of innovative tools to support increasingly personalized [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1920,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-1922","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FFCD and METHYS Dx: A Partnership Driving Innovation in Digestive Oncology | Methys DX<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FFCD and METHYS Dx: A Partnership Driving Innovation in Digestive Oncology | Methys DX\" \/>\n<meta property=\"og:description\" content=\"The F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive (FFCD) and METHYS Dx have decided to combine their expertise to contribute to the development of new approaches aimed at improving the monitoring of patients with digestive cancers. This partnership reflects a shared ambition: to advance clinical research and foster the emergence of innovative tools to support increasingly personalized [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Methys DX\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-06T08:23:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/methysdx.com\/wp-content\/uploads\/2026\/10\/ffcd2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"678\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin_methysDX\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_methysDX\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\\\/\"},\"author\":{\"name\":\"admin_methysDX\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/#\\\/schema\\\/person\\\/507d5a166b1f06448364f9269baddc83\"},\"headline\":\"FFCD and METHYS Dx: A Partnership Driving Innovation in Digestive Oncology\",\"datePublished\":\"2026-10-06T08:23:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\\\/\"},\"wordCount\":347,\"image\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/methysdx.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/ffcd2.png\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\\\/\",\"url\":\"https:\\\/\\\/methysdx.com\\\/en\\\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\\\/\",\"name\":\"FFCD and METHYS Dx: A Partnership Driving Innovation in Digestive Oncology | Methys DX\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/methysdx.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/ffcd2.png\",\"datePublished\":\"2026-10-06T08:23:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/#\\\/schema\\\/person\\\/507d5a166b1f06448364f9269baddc83\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/methysdx.com\\\/en\\\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/methysdx.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/ffcd2.png\",\"contentUrl\":\"https:\\\/\\\/methysdx.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/ffcd2.png\",\"width\":678,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/en\\\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/methysdx.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FFCD and METHYS Dx: A Partnership Driving Innovation in Digestive Oncology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/#website\",\"url\":\"https:\\\/\\\/methysdx.com\\\/\",\"name\":\"Methys DX\",\"description\":\"D\u00e9tection de signatures mol\u00e9culaires uniques sp\u00e9cifiques de diff\u00e9rents cancers par PCR digitale\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/methysdx.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/methysdx.com\\\/#\\\/schema\\\/person\\\/507d5a166b1f06448364f9269baddc83\",\"name\":\"admin_methysDX\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08689e3f90df7e20118cacbf580802bdab75ef8709129126791973d80930db17?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08689e3f90df7e20118cacbf580802bdab75ef8709129126791973d80930db17?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08689e3f90df7e20118cacbf580802bdab75ef8709129126791973d80930db17?s=96&d=mm&r=g\",\"caption\":\"admin_methysDX\"},\"url\":\"https:\\\/\\\/methysdx.com\\\/en\\\/author\\\/admin_methysdx\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FFCD and METHYS Dx: A Partnership Driving Innovation in Digestive Oncology | Methys DX","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/","og_locale":"en_US","og_type":"article","og_title":"FFCD and METHYS Dx: A Partnership Driving Innovation in Digestive Oncology | Methys DX","og_description":"The F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive (FFCD) and METHYS Dx have decided to combine their expertise to contribute to the development of new approaches aimed at improving the monitoring of patients with digestive cancers. This partnership reflects a shared ambition: to advance clinical research and foster the emergence of innovative tools to support increasingly personalized [&hellip;]","og_url":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/","og_site_name":"Methys DX","article_published_time":"2026-10-06T08:23:11+00:00","og_image":[{"width":678,"height":628,"url":"https:\/\/methysdx.com\/wp-content\/uploads\/2026\/10\/ffcd2.png","type":"image\/png"}],"author":"admin_methysDX","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_methysDX","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/#article","isPartOf":{"@id":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/"},"author":{"name":"admin_methysDX","@id":"https:\/\/methysdx.com\/#\/schema\/person\/507d5a166b1f06448364f9269baddc83"},"headline":"FFCD and METHYS Dx: A Partnership Driving Innovation in Digestive Oncology","datePublished":"2026-10-06T08:23:11+00:00","mainEntityOfPage":{"@id":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/"},"wordCount":347,"image":{"@id":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/methysdx.com\/wp-content\/uploads\/2026\/10\/ffcd2.png","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/","url":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/","name":"FFCD and METHYS Dx: A Partnership Driving Innovation in Digestive Oncology | Methys DX","isPartOf":{"@id":"https:\/\/methysdx.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/#primaryimage"},"image":{"@id":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/methysdx.com\/wp-content\/uploads\/2026\/10\/ffcd2.png","datePublished":"2026-10-06T08:23:11+00:00","author":{"@id":"https:\/\/methysdx.com\/#\/schema\/person\/507d5a166b1f06448364f9269baddc83"},"breadcrumb":{"@id":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/#primaryimage","url":"https:\/\/methysdx.com\/wp-content\/uploads\/2026\/10\/ffcd2.png","contentUrl":"https:\/\/methysdx.com\/wp-content\/uploads\/2026\/10\/ffcd2.png","width":678,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/methysdx.com\/en\/ffcd-and-methys-dx-a-partnership-driving-innovation-in-digestive-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/methysdx.com\/en\/"},{"@type":"ListItem","position":2,"name":"FFCD and METHYS Dx: A Partnership Driving Innovation in Digestive Oncology"}]},{"@type":"WebSite","@id":"https:\/\/methysdx.com\/#website","url":"https:\/\/methysdx.com\/","name":"Methys DX","description":"D\u00e9tection de signatures mol\u00e9culaires uniques sp\u00e9cifiques de diff\u00e9rents cancers par PCR digitale","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/methysdx.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/methysdx.com\/#\/schema\/person\/507d5a166b1f06448364f9269baddc83","name":"admin_methysDX","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/08689e3f90df7e20118cacbf580802bdab75ef8709129126791973d80930db17?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/08689e3f90df7e20118cacbf580802bdab75ef8709129126791973d80930db17?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/08689e3f90df7e20118cacbf580802bdab75ef8709129126791973d80930db17?s=96&d=mm&r=g","caption":"admin_methysDX"},"url":"https:\/\/methysdx.com\/en\/author\/admin_methysdx\/"}]}},"_links":{"self":[{"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/posts\/1922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/comments?post=1922"}],"version-history":[{"count":1,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/posts\/1922\/revisions"}],"predecessor-version":[{"id":1923,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/posts\/1922\/revisions\/1923"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/media\/1920"}],"wp:attachment":[{"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/media?parent=1922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/categories?post=1922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/methysdx.com\/en\/wp-json\/wp\/v2\/tags?post=1922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}